Article: Study reports results of PegIntron and Rebetol combination therapy for hepatitis.

2004 NOV 4 - (NewsRx.com & NewsRx.net) -- Patients infected with chronic hepatitis C virus (HCV) genotype 4 can be treated effectively and safely with individualized, weight-based PegIntron (peginterferon alfa-2b) and Rebetol (ribavirin) combination therapy, according to results of a new study published in the American Journal of Gastroenterology.

HCV genotype 4, one of the more difficult-to-treat strains of the virus, is the most predominant variant of the hepatitis C virus in the Middle East and North Africa, where the prevalence of HCV infection is one of the highest in the world.

"Our study establishes an important clinical benchmark for patients ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!